These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3946457)

  • 1. Cholesterol and coronary artery disease. What do clinicians do now?
    Levy RI
    Am J Med; 1986 Feb; 80(2A):18-22. PubMed ID: 3946457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.
    JAMA; 1984 Jan; 251(3):351-64. PubMed ID: 6361299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    Rifkind BM
    Am J Cardiol; 1984 Aug; 54(5):30C-34C. PubMed ID: 6382999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lipid Research Clinics Coronary Primary Prevention Trial.
    Rifkind BM
    Drugs; 1986; 31 Suppl 1():53-60. PubMed ID: 3720571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.
    JAMA; 1984 Jan; 251(3):365-74. PubMed ID: 6361300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of risk factor management in progression and regression of coronary and femoral artery atherosclerosis.
    Glueck CJ
    Am J Cardiol; 1986 May; 57(14):35G-41G. PubMed ID: 3521250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report on the Lipid Research Clinic trials.
    Levy RI
    Eur Heart J; 1987 Aug; 8 Suppl E():45-53. PubMed ID: 3315677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events.
    Whitney EJ; Krasuski RA; Personius BE; Michalek JE; Maranian AM; Kolasa MW; Monick E; Brown BG; Gotto AM
    Ann Intern Med; 2005 Jan; 142(2):95-104. PubMed ID: 15657157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hyperlipidemia.
    Gotto AM
    Am J Cardiol; 1986 May; 57(14):11G-16G. PubMed ID: 3521247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials including an update on the Helsinki Heart Study.
    Brown WV
    Am J Cardiol; 1990 Sep; 66(6):11A-15A. PubMed ID: 2203244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.
    Gordon DJ; Knoke J; Probstfield JL; Superko R; Tyroler HA
    Circulation; 1986 Dec; 74(6):1217-25. PubMed ID: 3536151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.
    Levy RI; Brensike JF; Epstein SE; Kelsey SF; Passamani ER; Richardson JM; Loh IK; Stone NJ; Aldrich RF; Battaglini JW
    Circulation; 1984 Feb; 69(2):325-37. PubMed ID: 6360415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol and cardiovascular disease. An overview of Lipid Research Clinics (LRC) epidemiologic studies as background for the LRC Coronary Primary Prevention Trial.
    Tyroler HA
    Am J Cardiol; 1984 Aug; 54(5):14C-19C. PubMed ID: 6382998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men.
    Krauss RM; Lindgren FT; Williams PT; Kelsey SF; Brensike J; Vranizan K; Detre KM; Levy RI
    Lancet; 1987 Jul; 2(8550):62-6. PubMed ID: 2885572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary and other correlates of changes in total and low density lipoprotein cholesterol in hypercholesterolemic men: the lipid research clinics coronary primary prevention trial.
    Glueck CJ; Gordon DJ; Nelson JJ; Davis CE; Tyroler HA
    Am J Clin Nutr; 1986 Oct; 44(4):489-500. PubMed ID: 3532756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study.
    Castelli WP; Anderson K
    Am J Med; 1986 Feb; 80(2A):23-32. PubMed ID: 3946458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing perspectives in the prevention of coronary artery disease.
    Levy RI
    Am J Cardiol; 1986 May; 57(14):17G-26G. PubMed ID: 3087152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS).
    Watts GF; Lewis B; Brunt JN; Lewis ES; Coltart DJ; Smith LD; Mann JI; Swan AV
    Lancet; 1992 Mar; 339(8793):563-9. PubMed ID: 1347091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in coronary heart disease: clinical and anatomical considerations.
    Satler LF; Pearle DL; Rackley CE
    Clin Cardiol; 1989 Aug; 12(8):422-6. PubMed ID: 2670383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease in women.
    Castelli WP
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1553-60, 1566-7. PubMed ID: 3377033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.